Patents by Inventor Venkateswarlu Jasti

Venkateswarlu Jasti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indazole compounds as 5-HTreceptor agonists
    Patent number: 9951045
    Abstract: The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxy-tryptamine 4 (5-HT4) receptor agonists.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: April 24, 2018
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Shankar Reddy Gagginapally, Venkateswarlu Jasti
  • PREPARATION OF WATER SOLUBLE TRIVALENT IRON CARBOHYDRATE COMPLEXES
    Publication number: 20180105609
    Abstract: The present invention provides an improved process for the preparation of Ferric carboxymaltose (FCM) complex. In this process the oxidation of maltodextrins are carried out by using an organic hypo halite in the presence of a catalyst and a phase transfer catalyst and later complex formation with ferric salt or ferric hydroxide or iron hydroxide maltodextrin complex.
    Type: Application
    Filed: May 6, 2015
    Publication date: April 19, 2018
    Inventors: Udaya Bhaskara Rao Siripalli, Lakshmi Narasimhulu Gorentla, Veera Reddy Arava, Mohana Rao Manam, Venkateswarlu Jasti
  • AMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
    Publication number: 20180051011
    Abstract: The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT4) receptor.
    Type: Application
    Filed: January 7, 2016
    Publication date: February 22, 2018
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Abdul Rasheed MOHAMMED, Sangram Keshari SARAF, Narsimha BOGARAJU, Ramkumar SUBRAMANIAN, Pradeep JAYARAJAN, Gopinadh BHYRAPUNENI, Venkateswarlu JASTI
  • Process for large scale production of N-[4-(1-cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochloride
    Patent number: 9802896
    Abstract: The present, invention relates to a process for large scale production of N-[4-(1-Cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochloride of formula (I).
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: October 31, 2017
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Ramasastri Kambhampati, Venkateswarlu Jasti
  • 5-amino-quinoline-8-carboxamide derivatives as 5-HT4 receptor agonists
    Patent number: 9790211
    Abstract: The present invention relates to novel quinoline compounds of formula (I), and their pharmaceutically acceptable salts and process for their preparation. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptor agonists.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: October 17, 2017
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Venkateswarlu Jasti
  • Process for the large scale production of 1H-[1,2,3]triazole and its intermediate 1-benzyl-1H-[1,2,3]triazole
    Patent number: 9783506
    Abstract: The present invention provides a process for the large scale production of 1H-[1,2,3]triazole of formula (I) and its intermediate 1-benzyl-1H-[1,2,3]triazole of formula (II) by using benzyl azide and vinyl acetate as starting materials. This process is economical, environment friendly and safer by avoiding use of special equipment.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: October 10, 2017
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Veera Reddy Arava, Sashibhushan Malreddy, Chalapathi Lagupudi, Venkateswarlu Jasti
  • PROCESS FOR LARGE SCALE PRODUCTION OF 1-ISOPROPYL-3--1H-INDAZOLE OXALATE
    Publication number: 20170283359
    Abstract: The present invention relates to a process suitable for adoption to large scale manufacture of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole oxalate of formula (I), which is a selective 5-HT4 receptor ligand intended for the symptomatic treatment of Alzheimer's disease and other disorders of memory and cognition like Attention deficient hyperactivity, Parkinson's and Schizophrenia.
    Type: Application
    Filed: October 23, 2014
    Publication date: October 5, 2017
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Abdul Rasheed MOHAMMED, Venkateswarlu JASTI
  • ACTIVE METABOLITE OF 1-[(2-BROMOPHENYL)SULFONYL]-5-METHOXY-3-[(4-METHYL-1-PIPERAZINYL)METHYL]-1H-INDOLE DIMESYLATE MONOHYDRATE AND DIMESYLATE DIHYDRATE SALT OF ACTIVE METABOLITE
    Publication number: 20170273944
    Abstract: The present invention is directed to active metabolite of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate of formula (I). The present invention is also directed to dimesylate dihydrate salt of formula (II). The compounds of formula (I) and formula (II) are useful in the treatment of various disorders that are related to 5-HT6 receptor antagonist.
    Type: Application
    Filed: October 20, 2014
    Publication date: September 28, 2017
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Ramasastri KAMBHAMPATI, Anil Karbhari SHINDE, Venkateswarlu JASTI
  • PROCESS FOR LARGE SCALE PRODUCTION OF N-[4-(1-CYCLOBUTYL PIPERIDIN-4-YLOXY) PHENYL]-2-(MORPHOLIN-4-YL) ACETAMIDE DIHYDROCHLORIDE
    Publication number: 20170260135
    Abstract: The present, invention relates to a process for large scale production of N-[4-(1-Cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochloride of formula (I).
    Type: Application
    Filed: October 20, 2014
    Publication date: September 14, 2017
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Ramasastri KAMBHAMPATI, Venkateswarlu JASTI
  • Heteroaryl compounds as 5-HTreceptor ligands
    Patent number: 9636335
    Abstract: The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: May 2, 2017
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Abdul Rasheed Mohammed, Suresh Yarlagadda, Srinivasa Rao Ravella, Anil Karbhari Shinde, Ramasastri Kambhampati, Praveen Kumar Roayapalley, Pradeep Jayarajan, Gopinadh Bhyrapuneni, Sriramachandra Murthy Patnala, Jyothsna Ravula, Venkateswarlu Jasti
  • Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate
    Patent number: 9540321
    Abstract: A process suitable for adoption to large scale manufacture of 1-[(2-bromophenyl-sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate, which is a selective 5-HT6 receptor antagonist intended for the symptomatic treatment of Alzheimer's disease and other disorders of memory and cognition like Attention deficient hyperactivity, Parkinson's and Schizophrenia.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: January 10, 2017
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Rama Sastri Kambhampati, Anil Karbhari Shinde, Venkateswarlu Jasti
  • Process for the preparation of Rosuvastatin calcium and preparation of its novel intermediates
    Patent number: 9518028
    Abstract: The present invention relates to process for the preparation of 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoic acid calcium having formula (I). The compound of formula (I) has adopted name “Rosuvastatin Calcium”. The present invention is also related to novel intermediates of formula (4) and formula (5) used in preparation of formula (I), and process of their preparation.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: December 13, 2016
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Udaya Bhaskara Rao Siripalli, Veera Reddy Arava, Rajendiran Chinnapillai, Anji Reddy Middekadi, Naresh Raju Makaraju, Venkateswarlu Jasti
  • INDAZOLE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
    Publication number: 20160311797
    Abstract: The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxy-tryptamine 4 (5-HT4) receptor agonists.
    Type: Application
    Filed: February 24, 2014
    Publication date: October 27, 2016
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Abdul Rasheed MOHAMMED, Anil Karbhari SHINDE, Shankar Reddy GAGGINAPALLY, Venkateswarlu JASTI
  • PROCESS FOR THE PREPARATION OF ROSUVASTATIN CALCIUM AND PREPARATION OF ITS NOVEL INTERMEDIATES
    Publication number: 20160304468
    Abstract: The present invention relates to process for the preparation of 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoic acid calcium having formula (I). The compound of formula (I) has adopted name “Rosuvastatin Calcium”. The present invention is also related to novel intermediates of formula (4) and formula (5) used in preparation of formula (I), and process of their preparation.
    Type: Application
    Filed: November 18, 2013
    Publication date: October 20, 2016
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Udaya Bhaskara Rao SIRIPALLI, Veera Reddy ARAVA, Rajendiran CHINNAPILLAI, Anji Reddy MIDDEKADI, Naresh Raju MAKARAJU, Venkateswarlu JASTI
  • PROCESS FOR LARGE SCALE PRODUCTION OF 1-[(2-BROMOPHENYL)SULFONYL]-5-METHOXY-3-[(4-METHYL-1-PIPERAZINYL)METHYL]-1H-INDOLE DIMESYLATE MONOHYDRATE
    Publication number: 20160297759
    Abstract: A process suitable for adoption to large scale manufacture of 1-[(2-bromophenyl-sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate, which is a selective 5-HT6 receptor antagonist intended for the symptomatic treatment of Alzheimer's disease and other disorders of memory and cognition like Attention deficient hyperactivity, Parkinson's and Schizophrenia.
    Type: Application
    Filed: February 20, 2014
    Publication date: October 13, 2016
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Rama Sastri KAMBHAMPATI, Anil Karbhari SHINDE, Venkateswarlu JASTI
  • 5-AMINO-QUINOLINE-8-CARBOXAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS
    Publication number: 20160280694
    Abstract: The present invention relates to novel quinoline compounds of formula (I), and their pharmaceutically acceptable salts and process for their preparation. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptor agonists.
    Type: Application
    Filed: October 18, 2013
    Publication date: September 29, 2016
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Venkateswarlu JASTI
  • PROCESS FOR THE LARGE SCALE PRODUCTION OF 1H-[1,2,3]TRIAZOLE AND ITS INTERMEDIATE 1-BENZYL-1H-[1,2,3]TRIAZOLE
    Publication number: 20160200691
    Abstract: The present invention provides a process for the large scale production of 1H-[1,2,3]triazole of formula (I) and its intermediate 1-benzyl-1H-[1,2,3]triazole of formula (II) by using benzyl azide and vinyl acetate as starting materials. This process is economical, environment friendly and safer by avoiding use of special equipment.
    Type: Application
    Filed: January 27, 2014
    Publication date: July 14, 2016
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Veera Reddy Arava, Sashibhushan Malreddy, Chalapathi Lagupudi, Venkateswarlu Jasti
  • Acrylamide compounds as histamine H3 receptor ligands
    Patent number: 9328092
    Abstract: The present invention relates to novel acrylamide compounds of formula (I): wherein A, X, R1, and Y are as defined herein, and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors.
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: May 3, 2016
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Adi Reddy Dwarampudi, Venkateswarlu Jasti
  • HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
    Publication number: 20150283125
    Abstract: The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
    Type: Application
    Filed: June 10, 2015
    Publication date: October 8, 2015
    Applicant: SUVEN LIFE SCIENCES LTD
    Inventors: Ramakrishna NIROGI, Abdul Rasheed MOHAMMED, Suresh YARLAGADDA, Srinivasa Rao RAVELLA, Anil Karbhari SHINDE, Ramasastri KAMBHAMPATI, Praveen Kumar ROAYAPALLEY, Pradeep JAYARAJAN, Gopinadh BHYRAPUNENI, Sriramachandra Murthy PATNALA, Jyothsna RAVULA, Venkateswarlu JASTI
  • ACRYLAMIDE COMPOUNDS AS HISTAMINE H3 RECEPTOR LIGANDS
    Publication number: 20150218129
    Abstract: The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. (The chemical formula should be inserted here.) The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors.
    Type: Application
    Filed: December 5, 2012
    Publication date: August 6, 2015
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Adi Reddy Dwarampudi, Venkateswarlu Jasti